Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Opening a Pandora's Box that can't be salvaged: Health professionals' perceptions of appearance-related care in an Australian pediatric specialist hospital.

Gee C, Maskell J, Newcombe P, Kimble R, Williamson H.

Body Image. 2019 Dec;31:1-12. doi: 10.1016/j.bodyim.2019.07.004. Epub 2019 Aug 27.

PMID:
31465991
2.

Challenges of recruiting adolescents for appearance-related research in a specialist tertiary hospital.

Gee C, Williamson H, Maskell J, Kimble R, Newcombe P.

J Paediatr Child Health. 2018 Nov;54(11):1176-1179. doi: 10.1111/jpc.13942. Epub 2018 May 13. No abstract available.

PMID:
29754450
3.

Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.

Landis S, Suruki R, Maskell J, Bonar K, Hilton E, Compton C.

COPD. 2018 Apr;15(2):177-184. doi: 10.1080/15412555.2018.1441275. Epub 2018 Mar 20.

PMID:
29558236
4.

Epidemiology of hyperhidrosis in 2 population-based health care databases.

Ricchetti-Masterson K, Symons JM, Aldridge M, Patel A, Maskell J, Logie J, Yamaguchi Y, Cook SF.

J Am Acad Dermatol. 2018 Feb;78(2):358-362. doi: 10.1016/j.jaad.2017.10.004. Epub 2017 Oct 6.

PMID:
28993234
5.

Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey.

Müllerová H, Landis SH, Aisanov Z, Davis KJ, Ichinose M, Mannino DM, Maskell J, Menezes AM, van der Molen T, Oh YM, Tabberer M, Han MK.

Int J Chron Obstruct Pulmon Dis. 2016 Apr 27;11:881-90. doi: 10.2147/COPD.S102280. eCollection 2016. Erratum in: Int J Chron Obstruct Pulmon Dis. 2017 Mar 15;12 :859.

6.

Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries.

Foo J, Landis SH, Maskell J, Oh YM, van der Molen T, Han MK, Mannino DM, Ichinose M, Punekar Y.

PLoS One. 2016 Apr 19;11(4):e0152618. doi: 10.1371/journal.pone.0152618. eCollection 2016.

7.

Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink Study.

Robson JC, Kiran A, Maskell J, Hutchings A, Arden N, Dasgupta B, Hamilton W, Emin A, Culliford D, Luqmani R.

J Rheumatol. 2016 Jun;43(6):1085-92. doi: 10.3899/jrheum.151024. Epub 2016 Apr 15.

PMID:
27084910
8.

Incidence and risk factors for food hypersensitivity in UK infants: results from a birth cohort study.

Grimshaw KE, Bryant T, Oliver EM, Martin J, Maskell J, Kemp T, Clare Mills EN, Foote KD, Margetts BM, Beyer K, Roberts G.

Clin Transl Allergy. 2016 Jan 26;6:1. doi: 10.1186/s13601-016-0089-8. eCollection 2015.

9.

Prospective food diaries demonstrate breastfeeding characteristics in a UK birth cohort.

Grimshaw KE, Aksoy B, Palmer A, Jenner K, Oliver EM, Maskell J, Kemp T, Foote KD, Roberts GC, Ellahi B, Margetts BM.

Matern Child Nutr. 2015 Oct;11(4):703-11. doi: 10.1111/mcn.12052. Epub 2013 Jun 18.

PMID:
26419217
10.

Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study.

DiBello JR, Ioannou C, Rees J, Challacombe B, Maskell J, Choudhury N, Kastner C, Kirby M.

BJU Int. 2016 May;117(5):801-8. doi: 10.1111/bju.13334. Epub 2015 Oct 26.

11.

Future projections of total hip and knee arthroplasty in the UK: results from the UK Clinical Practice Research Datalink.

Culliford D, Maskell J, Judge A, Cooper C, Prieto-Alhambra D, Arden NK; COASt Study Group.

Osteoarthritis Cartilage. 2015 Apr;23(4):594-600. doi: 10.1016/j.joca.2014.12.022. Epub 2015 Jan 9.

12.

Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study.

Prieto-Alhambra D, Javaid MK, Judge A, Maskell J, Cooper C, Arden NK; COASt Study Group.

Ann Rheum Dis. 2015 Mar;74(3):557-63. doi: 10.1136/annrheumdis-2013-204043. Epub 2014 Jan 22.

PMID:
24451241
13.
14.

Introduction of complementary foods and the relationship to food allergy.

Grimshaw KE, Maskell J, Oliver EM, Morris RC, Foote KD, Mills EN, Roberts G, Margetts BM.

Pediatrics. 2013 Dec;132(6):e1529-38. doi: 10.1542/peds.2012-3692. Epub 2013 Nov 18.

PMID:
24249826
15.

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK.

Robson JC, Kiran A, Maskell J, Hutchings A, Arden N, Dasgupta B, Hamilton W, Emin A, Culliford D, Luqmani RA.

Ann Rheum Dis. 2015 Jan;74(1):129-35. doi: 10.1136/annrheumdis-2013-204113. Epub 2013 Oct 4.

PMID:
24095936
16.

Diet and food allergy development during infancy: birth cohort study findings using prospective food diary data.

Grimshaw KE, Maskell J, Oliver EM, Morris RC, Foote KD, Mills EN, Margetts BM, Roberts G.

J Allergy Clin Immunol. 2014 Feb;133(2):511-9. doi: 10.1016/j.jaci.2013.05.035. Epub 2013 Jul 23.

PMID:
23891269
17.

Psychological and psychosocial functioning of children with burn scarring using cosmetic camouflage: a multi-centre prospective randomised controlled trial.

Maskell J, Newcombe P, Martin G, Kimble R.

Burns. 2014 Feb;40(1):135-49. doi: 10.1016/j.burns.2013.04.025. Epub 2013 Jun 13.

PMID:
23770131
18.

Psychosocial functioning differences in pediatric burn survivors compared with healthy norms.

Maskell J, Newcombe P, Martin G, Kimble R.

J Burn Care Res. 2013 Jul-Aug;34(4):465-76. doi: 10.1097/BCR.0b013e31827217a9.

PMID:
23702857
19.

Conducting a paediatric multi-centre RCT with an industry partner: challenges and lessons learned.

Maskell J, Newcombe P, Martin G, Kimble R.

J Paediatr Child Health. 2012 Nov;48(11):974-7. doi: 10.1111/j.1440-1754.2012.02510.x. Epub 2012 Aug 14.

PMID:
22892018
20.

The lifetime risk of total hip and knee arthroplasty: results from the UK general practice research database.

Culliford DJ, Maskell J, Kiran A, Judge A, Javaid MK, Cooper C, Arden NK.

Osteoarthritis Cartilage. 2012 Jun;20(6):519-24. doi: 10.1016/j.joca.2012.02.636. Epub 2012 Mar 3.

21.

Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use.

Prieto-Alhambra D, Javaid MK, Judge A, Maskell J, Kiran A, de Vries F, Cooper C, Arden NK.

Arthritis Rheum. 2011 Apr;63(4):992-1001. doi: 10.1002/art.30214.

22.

Mortality in Wegener's granulomatosis: a bimodal pattern.

Luqmani R, Suppiah R, Edwards CJ, Phillip R, Maskell J, Culliford D, Jayne D, Morishita K, Arden N.

Rheumatology (Oxford). 2011 Apr;50(4):697-702. doi: 10.1093/rheumatology/keq351. Epub 2010 Nov 25.

PMID:
21112869
23.

The effect of hip and knee arthroplasty on oral anti-inflammatory use and the relationship to body mass index: results from the UK general practice research database.

Bolland BJ, Culliford DJ, Maskell J, Latham JM, Dunlop DG, Arden NK.

Osteoarthritis Cartilage. 2011 Jan;19(1):29-36. doi: 10.1016/j.joca.2010.10.012. Epub 2010 Oct 27.

24.

Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study.

Prieto-Alhambra D, Javaid MK, Maskell J, Judge A, Nevitt M, Cooper C, Arden NK.

Ann Rheum Dis. 2011 Jan;70(1):134-8. doi: 10.1136/ard.2010.131110. Epub 2010 Oct 26.

PMID:
20980287
25.

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis.

Prieto-Alhambra D, Javaid MK, Judge A, Maskell J, Kiran A, Cooper C, Arden NK.

Osteoporos Int. 2011 May;22(5):1555-71. doi: 10.1007/s00198-010-1368-1. Epub 2010 Aug 7.

PMID:
20694456
26.

Temporal trends in hip and knee replacement in the United Kingdom: 1991 to 2006.

Culliford DJ, Maskell J, Beard DJ, Murray DW, Price AJ, Arden NK.

J Bone Joint Surg Br. 2010 Jan;92(1):130-5. doi: 10.1302/0301-620X.92B1.22654.

PMID:
20044691
27.

Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database.

Moore M, Yuen HM, Dunn N, Mullee MA, Maskell J, Kendrick T.

BMJ. 2009 Oct 15;339:b3999. doi: 10.1136/bmj.b3999. Erratum in: BMJ. 2009;339:b4361.

28.

A rapid microplate method for quantifying inhibition of bacterial adhesion to eukaryotic cells.

Acord J, Maskell J, Sefton A.

J Microbiol Methods. 2005 Jan;60(1):55-62.

PMID:
15567225
30.
31.

Amino acid repetitions in the dihydropteroate synthase of Streptococcus pneumoniae lead to sulfonamide resistance with limited effects on substrate K(m).

Haasum Y, Ström K, Wehelie R, Luna V, Roberts MC, Maskell JP, Hall LM, Swedberg G.

Antimicrob Agents Chemother. 2001 Mar;45(3):805-9.

32.

Selection of resistant variants of respiratory pathogens by quinolones.

Sefton AM, Maskell JP, Williams JD.

Int J Antimicrob Agents. 1999 Jul;12(2):129-34.

PMID:
10418757
33.

In vitro activity of grepafloxacin against Haemophilus influenzae and Moraxella catarrhalis.

Maskell JP, Whiley AC, Sefton AM.

Eur J Clin Microbiol Infect Dis. 1998 Apr;17(4):293-5. No abstract available.

PMID:
9707317
34.

Mechanism of sulfonamide resistance in clinical isolates of Streptococcus pneumoniae.

Maskell JP, Sefton AM, Hall LM.

Antimicrob Agents Chemother. 1997 Oct;41(10):2121-6. Erratum in: Antimicrob Agents Chemother 2000 May;44(5):1411.

35.

The in-vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteria.

Sefton AM, Maskell JP, Rafay AM, Whiley A, Williams JD.

J Antimicrob Chemother. 1997 Jun;39 Suppl B:57-62.

PMID:
9222071
36.

Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp.

Williams JD, Maskell JP, Whiley AC, Sefton AM.

J Antimicrob Chemother. 1997 May;39 Suppl A:41-6.

PMID:
9511061
37.

Azithromycin in the treatment of periodontal disease. Effect on microbial flora.

Sefton AM, Maskell JP, Beighton D, Whiley A, Shain H, Foyle D, Smith SR, Smales FC, Williams JD.

J Clin Periodontol. 1996 Nov;23(11):998-1003.

PMID:
8951627
38.

Comparative in-vitro activity of CP-99219, a new quinolone, against respiratory pathogens.

Sefton AM, Maskell JP, Seymour AC, Minassian M, Williams JD.

J Antimicrob Chemother. 1996 Apr;37(4):803-8.

PMID:
8722546
39.

Electrophoretic analysis of the lipopolysaccharides of Bacteroides spp.

Maskell JP.

Antonie Van Leeuwenhoek. 1994;65(2):155-61.

PMID:
7979320
40.

Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.

Williams JD, Maskell JP, Shain H, Chrysos G, Sefton AM, Fraser HY, Hardie JM.

J Antimicrob Chemother. 1992 Jul;30(1):27-37.

PMID:
1331019
41.

Protective efficacy of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae in a murine septicaemia model.

Chen HY, Maskell JP, Powell M.

J Antimicrob Chemother. 1992 May;29(5):602-3. No abstract available.

PMID:
1385590
42.

Failure of two macrolide antibiotics to prevent post-extraction bacteraemia.

Cannell H, Kerawala C, Sefton AM, Maskell JP, Seymour A, Sun ZM, Williams JD.

Br Dent J. 1991 Sep 21;171(6):170-3.

PMID:
1832916
43.

Fine molecular specificity of linear and assembled antibody binding sites in HIV-1 p24.

Haaheim LR, Maskell JP, Mascagni P, Coates AR.

Scand J Immunol. 1991 Sep;34(3):341-50.

PMID:
1715604
44.
45.

Predominance of resistant oral streptococci in saliva and the effect of a single course of josamycin or erythromycin.

Maskell JP, Sefton AM, Cannell H, Kerawala C, Seymour A, Sun ZM, Williams JD.

J Antimicrob Chemother. 1990 Oct;26(4):539-48.

PMID:
2254223
46.

Comparative efficacy and tolerance of erythromycin and josamycin in the prevention of bacteraemia following dental extraction.

Sefton AM, Maskell JP, Kerawala C, Cannell H, Seymour A, Sun ZM, Williams JD.

J Antimicrob Chemother. 1990 Jun;25(6):975-84.

PMID:
2196261
47.

Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes.

Maskell JP, Sefton AM, Williams JD.

J Antimicrob Chemother. 1990 Jan;25 Suppl A:19-24.

PMID:
2154433
48.

In-vitro activity of lomefloxacin (SC-47111) and other quinolones.

Sun ZM, Maskell JP, Sehgal SC, Williams JD.

Infection. 1989 May-Jun;17(3):165-7.

PMID:
2737760
49.

Comparative inhibitory and bactericidal activities of FCE 22101 against gram-positive cocci and anaerobes in vitro.

Maskell JP, Tang T, Asad S, Williams JD.

J Antimicrob Chemother. 1989 Mar;23 Suppl C:65-74.

PMID:
2732145
50.

Comparative in vitro activity of A-56268.

Sefton AM, Maskell JP, Yong FJ, Chi SJ, Williams JD.

Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):798-802.

PMID:
2975218

Supplemental Content

Loading ...
Support Center